Abstract | BACKGROUND: New therapies blocking the IL-6 receptor (IL-6R) have recently become available and are successfully being used to treat inflammatory diseases like arthritis. Whether IL-6 blockers may help patients with kidney inflammation currently remains unknown. METHODS: To learn more about the complex role of CD4+ T cell-intrinsic IL-6R signaling, we induced nephrotoxic nephritis, a mouse model for crescentic GN, in mice lacking T cell-specific IL-6Ra. We used adoptive transfer experiments and studies in reporter mice to analyze immune responses and Treg subpopulations. RESULTS: Lack of IL-6Ra signaling in mouse CD4+ T cells impaired the generation of proinflammatory Th17 cells, but surprisingly did not ameliorate the course of GN. In contrast, renal damage was significantly reduced by restricting IL-6Ra deficiency to T effector cells and excluding Tregs. Detailed studies of Tregs revealed unaltered IL-10 production despite IL-6Ra deficiency. However, in vivo and in vitro, IL-6Ra classic signaling induced RORγt+Foxp3+ double-positive Tregs (biTregs), which carry the trafficking receptor CCR6 and have potent immunoregulatory properties. Indeed, lack of IL-6Ra significantly reduced Treg in vitro suppressive capacity. Finally, adoptive transfer of T cells containing IL-6Ra-/- Tregs resulted in severe aggravation of GN in mice. CONCLUSIONS: Our data refine the old paradigm, that IL-6 enhances Th17 responses and suppresses Tregs. We here provide evidence that T cell-intrinsic IL-6Ra classic signaling indeed induces the generation of Th17 cells but at the same time highly immunosuppressive RORγt+ biTregs. These results advocate caution and indicate that IL-6-directed therapies for GN need to be cell-type specific.
|
Authors | Julia Hagenstein, Simon Melderis, Anna Nosko, Matthias T Warkotsch, Johannes V Richter, Torben Ramcke, Georg R Herrnstadt, Jürgen Scheller, Isabell Yan, Hans-Willi Mittrücker, Malte A Kluger, Oliver M Steinmetz |
Journal | Journal of the American Society of Nephrology : JASN
(J Am Soc Nephrol)
Vol. 30
Issue 8
Pg. 1439-1453
(08 2019)
ISSN: 1533-3450 [Electronic] United States |
PMID | 31311828
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 by the American Society of Nephrology. |
Chemical References |
- FOXP3 protein, human
- Forkhead Transcription Factors
- Il6ra protein, mouse
- Immunosuppressive Agents
- Interleukin-6 Receptor alpha Subunit
- Nuclear Receptor Subfamily 1, Group F, Member 3
- Receptors, Interleukin-6
- Rorc protein, mouse
|
Topics |
- Animals
- Cell Line
- Crosses, Genetic
- Female
- Forkhead Transcription Factors
(metabolism)
- Glomerulonephritis
(metabolism, pathology)
- Immunosuppressive Agents
(therapeutic use)
- Inflammation
- Interleukin-6 Receptor alpha Subunit
(genetics, metabolism)
- Male
- Mice
- Mice, Inbred C57BL
- Necrosis
- Nuclear Receptor Subfamily 1, Group F, Member 3
(metabolism)
- Receptors, Interleukin-6
(genetics, metabolism)
- Signal Transduction
- T-Lymphocytes, Regulatory
(immunology)
- Th17 Cells
(cytology)
|